David Sm13e Cn 21

8/13/2019 David Sm13e Cn 21

1/21

Johnson & Johnson - 2009Case Notes Prepared by: Dr. Mernoush Banton

Case Authors: Sharynn To!"n# Matt M"!hauser# Bernhard $"er%e#Th"bau!t e'eb(re# and Mar"o Mart"ne)

A. Case Abstract

Johnson & Johnson *+++.JNJ.,o "s a ,oprehens"(e strate", anaeent,ase that "n,!udes the ,opany/s ,a!endar De,eber 1# 200 '"nan,"a!stateents# ,opet"tor "n'orat"on and ore. The ,ase t"e sett"n "s the year2009. Su''","ent "nterna! and e3terna! data are pro("ded to enab!e students toe(a!uate ,urrent strate"es and re,oend a three-year strate", p!an 'or the,opany. 4ead5uartered "n Ne+ Bruns+",%# Ne+ Jersey# Johnson & Johnson "straded on the Ne+ 6or% Sto,% 73,hane under t",%er sybo! JNJ.

B. Vision Statement *A,tua!

To a3"")e the !oba! po+er o' d"(ers"ty and "n,!us"on to dr"(e super"orbus"ness resu!ts and susta"nab!e ,opet"t"(e ad(antae.

C. Mission Statement *A,tua!

8e be!"e(e our '"rst respons"b"!"ty "s to the do,tors# nurses and pat"ents# toothers and 'athers and a!! others +ho use our produ,ts and ser(",es. n

eet"n the"r needs# e(eryth"n +e do ust be o' h"h 5ua!"ty. *1# 2

8e ust ,onstant!y str"(e to redu,e our ,osts "n order to a"nta"n reasonab!epr",es. Custoers/ orders ust be ser(",ed propt!y and a,,urate!y. ursupp!"ers and d"str"butors ust ha(e an opportun"ty to a%e a 'a"r pro'"t. *;

8e are respons"b!e to our ep!oyees# the en and +oen +ho +or% +"th usthrouhout the +or!d. 7(eryone ust be ,ons"dered as an "nd"("dua!. 8e ustrespe,t the"r d"n"ty and re,on")e the"r er"t. They ust ha(e a sense o'se,ur"ty "n the"r

8/13/2019 David Sm13e Cn 21

2/21

"pro(eents and better hea!th and edu,at"on. 8e ust a"nta"n "n ood orderthe property +e are pr"("!eed to use# prote,t"n the en("ronent and natura!resour,es. *# ?#

ur '"na! respons"b"!"ty "s to our sto,%ho!ders. Bus"ness ust a%e a sound pro'"t.

8e ust e3per"ent +"th ne+ "deas. @esear,h ust be ,arr"ed on# "nno(at"(eproras de(e!oped and "sta%es pa"d 'or. Ne+ e5u"pent ust be pur,hased#ne+ 'a,"!"t"es pro("ded and ne+ produ,ts !aun,hed. @eser(es ust be ,reated topro("de 'or ad(erse t"es. 8hen +e operate a,,ord"n to these pr"n,"p!es# thesto,%ho!ders shou!d rea!")e a 'a"r return. *#

1. Custoer2. Produ,ts or ser(",es. Mar%ets. Te,hno!oy. Con,ern 'or sur("(a!# pro'"tab"!"ty# ro+th

;. Ph"!osophy?. Se!'-,on,ept. Con,ern 'or pub!", "ae9. Con,ern 'or ep!oyees

D. External Audit

CPM Competitive Profile Matrix

JJ P! "t#er

Critical Success$actors

%eit

'atin&

%eited Score

'atin&

%eited Score

'atin&

%eitedScore

Pr",e ,opet"t"(eness 0.11 0. 2 0.22 0.

$!oba! 73pans"on 0.10 0.0 0.0 2 0.20ran")at"ona!Stru,ture 0.0 0.12 2 0.0 0.1;

7p!oyee Mora!e 0.0 0.20 0.1 2 0.10

Te,hno!oy 0.10 0.0 0.0 2 0.20

Produ,t Sa'ety 0.11 0. 0. 2 0.22

Custoer oya!ty 0.10 0.0 0.0 2 0.20

Mar%et Share 0.0; 0.2 0.1 2 0.12

Ad(ert"s"n 0.0 0.2 0.2 2 0.1;

Produ,t ua!"ty 0.10 0.0 0.0 2 0.20

Produ,t ae 0.0 0.2 0.2 2 0.1;

"nan,"a! Pos"t"on 0.0? 0.2 0.21 2 0.1

(otal ).** +.,, -.+ -.)

Copyr"ht > 2011 Pearson 7du,at"on# n,. pub!"sh"n as Prent",e 4a!!.

8/13/2019 David Sm13e Cn 21

3/21

"pportunities

1. Sa!!er ,opan"es are ,o"n up +"th ne+ and "nno(at"(e drus. Th"s

,reates an opportun"ty 'or !arer dru ,opan"es to a,5u"re or 'or a

8/13/2019 David Sm13e Cn 21

4/21

1e2 External $actors %eit 'atin& %eitedScore


8/13/2019 David Sm13e Cn 21

5/21

"pportunities

1. Sa!!er ,opan"es are ,o"n up +"th ne+and "nno(at"(e drus. Th"s ,reates anopportun"ty 'or !arer dru ,opan"es toa,5u"re or 'or a 2011 Pearson 7du,at"on# n,. pub!"sh"n as Prent",e 4a!!.

8/13/2019 David Sm13e Cn 21

6/21

ar%et

. ntrodu,"n a ne+ dru "nto the ar%et ,anta%e 10 to 1 years and re5u"re e3tens"(eaount o' oney to et "t tested and re,e"(e

DA appro(a!

0.0 1 0.0

;. 'ten# drus ,ou!d ha(e s"de e''e,ts +h",h,reate neat"(e pub!","ty and F or 'or,e the,opany to re,a!! the dru or reo(e "t 'rothe she!(es

0.0? 2 0.1

(otal ).** -.,

Positionin& Map

E. 3nternal Audit

Stren&t#s


Brand oya!ty*4"h

Brandoya!ty*o+

nno(at"on *4"h

nno(at"on *o+

Johnson &Johnson

Pro,ter &$ab!e

P'")erNo(art"s

Mer,% &Co.

8/13/2019 David Sm13e Cn 21

7/21

1. J&J o''ers a +"de (ar"ety o' produ,ts and ser(",es to hosp"ta!s# reta"!ers#and 'a"!"es

2. The ,opany does bus"ness "n three seents: phara,eut",a!# ed",a!de(",es and ,onsuer produ,ts

. n Ju!y 2009# J&J pur,hased an 1. per,ent sta%e "n r"sh b"ote,h

,opany 7!an Corp. "n order to a"n a,,ess to the G b"!!"on ar%et 'orA!)he"er/s d"sease treatents. The e''e,t"(eness o' the dru ,ou!d he!pthe ,opany/s sa!es by G2 b"!!"on

. n 2009# J&J a,5u"red the sa!! ,an,er dru-de(e!oper CouarB"ote,hno!oy 'or about G9 "!!"on "n ,ash. Couar has an e3,e!!entdru 'or !ate stae prostate ,an,er

. At the end o' 200# J&J reported G?.; b"!!"on "n resear,h andde(e!opents e3pend"tures# +h",h +as a s!"ht de,rease 'ro 200?

;. Sa!es 'or both ,onsuer hea!th produ,ts and ed",a! de(",es andd"anost",s +ere up 'ro 200? to 200 by 10. per,ent and ;. per,ent#respe,t"(e!y

?. The ,onsuer produ,ts seent/s operat"n pro'"t "n,reased 1?. per,ent'ro 200? to G2#;? "!!"on "n 200. The Phara,eut",a! seent operat"n pro'"t "n,reased 1;. per,ent 'ro

200?# and operat"n pro'"t "n,reased to 1.0 per,ent to a tota! o' G?#;0"!!"on "n 200

9. perat"n pro'"t "n ed",a! de(",es seent "n,reased 9.1 per,ent 'ro200? to a tota! o' G?#22 "!!"on "n 200

%ea4nesses

1. Sa!es 'or phara,eut",a! seent +as do+n 'ro 200? to 200 by 1.2per,ent

2. Patent on any o' the"r popu!ar and h"h (o!ue drus "s about to e3p"re. n,rease "n tota! !"ab"!"t"es by appro3"ate!y G. b"!!"on 'ro 200? to 200. n re,ent years# ha(e not "ntrodu,ed any ne+ "nno(at"(e produ,t un!ess by

a,5u"r"n other ,opan"es. Per 2009 data# the ,opany/s 5uarter!y sa!es dropped by . per,ent 'ro

the sae per"od "n pr"or year;. The se!!"n# enera! and ad"n"strat"n e3penses to sa!es "n,reased by

0.0 per,ent 'ro 200? to 200

$inancial 'atio Anal2sis *De,eber 2009!ro5t# 'ates 6 JJ 3ndustr2 SP 7**

Sa!es *tr (s year ao 5tr -.0 .20 -.0

Net n,oe *6TD (s 6TD -1.?0 .10 -;.00

Net n,oe *tr (s year ao 5tr 1.10 .0 2;.0

Sa!es *-6ear Annua! A(. .?? .9 12.99

Net n,oe *-6ear Annua! A(. 12.; 1. 12.;9


8/13/2019 David Sm13e Cn 21

8/21

D"("dends *-6ear Annua! A(. 1.1 1.0 11.

Price 'atios JJ 3ndustr2 SP 7**

Current PF7 @at"o 1.1 1. 2;.?

PF7 @at"o -6ear 4"h 2. 1.2 1;.;

PF7 @at"o -6ear o+ 10. .0 2.;

Pr",eFSa!es @at"o 2.9 .0 2.2

Pr",eFBoo% Ea!ue . .10 .

Pr",eFCash !o+ @at"o 11.0 12.20 1.?0

Profit Mar&ins 6 JJ 3ndustr2 SP 7**

$ross Mar"n ?1.1 ?2.9 .9

Pre-Ta3 Mar"n 2?. 2.0 10.

Net Pro'"t Mar"n 21.1 1.? ?.1

6r $ross Mar"n *-6ear A(. ?1. ?2.1 .;6r PreTa3 Mar"n *-6ear A(. 2. 21. 1;.;

6r Net Pro'"t Mar"n *-6ear A(. 19.1 1.9 11.

$inancial Condition JJ 3ndustr2 SP 7**

DebtF75u"ty @at"o 0.2 2.0 1.09

Current @at"o 1. 1.9 1.

u",% @at"o 1.; 1.; 1.

nterest Co(erae ?.1 20.; 2.?

e(erae @at"o 1. .? .Boo% Ea!ueFShare 1.2? 11.1 21.;Adapted 'ro +++.oney,entra!.sn.,o

Av& P8E Price8 Sales Price8 Boo49et Profit

Mar&in /60

12F0 1.20 2.;0 .1 20.

12F0? 1?.;0 .21 .2 1?.

12F0; 1;.?0 .;? .; 20.?

01F0; 19.0 .? .;2 19.9

01F0 20.0 .01 .92 1?.12F0 22.00 .; .9 1?.2

12F02 2;.;0 .? ;.9 1.2

12F01 2.0 .;? ?. 1?.

12F00 2?.;0 . ?.?; 1?.0

12F0 1.20 2.;0 .1 20.

http://www.moneycentral.msn.com/http://www.moneycentral.msn.com/

8/13/2019 David Sm13e Cn 21

9/21

Boo4 Value8

S#are

Debt8

E:uit2

'eturn on

E:uit2 /60

'eturn on

Assets /60

3nterest

Covera&e

12F0 G1. 0.2 0. 1.2 .9

12F0? G1.2 0.22 2. 1.1 .9

12F0; G1.9 0.1? 2.1 1.? 21.

01F0; G1.01 0.0? 2;.0 1?.1 22.9

01F0 G10.?1 0.09 2.? 1. ;.9

12F0 G9.0 0.1 2;. 1.9 9.

12F02 G?.; 0.1 29.1 1;. .1

12F01 G?.9 0.11 2. 1.? 1.;

12F00 G;.?? 0.2 2. 1. .?

12F0 G1. 0.2 0. 1.2 .9Adapted 'ro +++.oney,entra!.sn.,o

3nternal $actor Evaluation /3$E0 Matrix

1e2 3nternal $actors %eit 'atin& %eitedScore

Stren&t#s

1. J&J o''ers a +"de (ar"ety o' produ,ts andser(",es to hosp"ta!s# reta"!ers# and 'a"!"es

0.0 0.2

2. The ,opany does bus"ness "n threeseents: phara,eut",a!# ed",a! de(",esand ,onsuer produ,ts

0.0 0.2

. n Ju!y 2009# J&J pur,hased an 1. per,entsta%e "n r"sh b"ote,h ,opany 7!an Corp. "norder to a"n a,,ess to the G b"!!"on ar%et'or A!)he"erHs d"sease treatents. Thee''e,t"(eness o' the dru ,ou!d he!p the,opanyHs sa!es by G2 b"!!"on

0.0? 0.2

. n 2009# J&J a,5u"red the sa!! ,an,er dru-de(e!oper Couar B"ote,hno!oy 'or aboutG9 "!!"on "n ,ash. Couar has an e3,e!!entdru 'or !ate stae prostate ,an,er

0.0? 0.2

. At the end o' 200# J&J reported G?.; b"!!"on"n resear,h and de(e!opents e3pend"tures#

+h",h +as a s!"ht de,rease 'ro 200?

0.0 0.2

;. Sa!es 'or both ,onsuer hea!th produ,ts anded",a! de(",es and d"anost",s +ere up 'ro200? to 200 by 10. per,ent and ;.per,ent# respe,t"(e!y

0.0; 0.1

?. The ,onsuer produ,ts seentHs operat"npro'"t "n,reased 1?. per,ent 'ro 200? toG2#;? "!!"on "n 200

0.0; 0.1

http://www.moneycentral.msn.com/http://www.moneycentral.msn.com/

8/13/2019 David Sm13e Cn 21

10/21

. The Phara,eut",a! seent operat"n pro'"t"n,reased 1;. per,ent 'ro 200?# andoperat"n pro'"t "n,reased to 1.0 per,ent to atota! o' G?#;0 "!!"on "n 200

0.0; 0.1

9. perat"n pro'"t "n ed",a! de(",es seent"n,reased 9.1 per,ent 'ro 200? to a tota! o'

G?#22 "!!"on "n 200

0.0; 0.1

%ea4nesses

1. Sa!es 'or phara,eut",a! seent +as do+n'ro 200? to 200 by 1.2 per,ent

0.0; 1 0.0;

2. Patent on any o' the"r popu!ar and h"h(o!ue drus "s about to e3p"re

0.09 1 0.09

. n,rease "n tota! !"ab"!"t"es by appro3"ate!yG. b"!!"on 'ro 200? to 200

0.0 2 0.1

. n re,ent years# ha(e not "ntrodu,ed any ne+"nno(at"(e produ,t un!ess by a,5u"r"n other,opan"es

0.0? 1 0.0?

. Per 2009 data# the ,opanyHs 5uarter!y sa!esdropped by . per,ent 'ro the sae per"od"n pr"or year

0.0 2 0.0

;. The se!!"n# enera! and ad"n"strat"ne3penses to sa!es "n,reased by 0.0 per,ent'ro 200? to 200

0.0? 2 0.1

(otal ).** -.;

$. S%"( Strate&ies

Stren&t#s %ea4nesses

1. J&J o''ers a +"de (ar"etyo' produ,ts and ser(",esto hosp"ta!s# reta"!ers#and 'a"!"es

2. The ,opany doesbus"ness "n threeseents:phara,eut",a!# ed",a!de(",es and ,onsuerprodu,ts

. n Ju!y 2009# J&Jpur,hased an 1.per,ent sta%e "n r"sh

1. Sa!es 'or phara,eut",a!seent +as do+n 'ro200? to 200 by 1.2per,ent

2. Patent on any o' the"rpopu!ar and h"h (o!uedrus "s about to e3p"re

. n,rease "n tota!!"ab"!"t"es byappro3"ate!y G.b"!!"on 'ro 200? to 200

. n re,ent years# ha(e not"ntrodu,ed any ne+


8/13/2019 David Sm13e Cn 21

11/21

b"ote,h ,opany 7!anCorp. "n order to a"na,,ess to the G b"!!"onar%et 'or A!)he"er/sd"sease treatents.

The e''e,t"(eness o' thedru ,ou!d he!p the,opany/s sa!es by G2b"!!"on

. n 2009# J&J a,5u"redthe sa!! ,an,er dru-de(e!oper CouarB"ote,hno!oy 'or aboutG9 "!!"on "n ,ash.Couar has an e3,e!!entdru 'or !ate stae

prostate ,an,er. At the end o' 200# J&Jreported G?.; b"!!"on "nresear,h andde(e!opentse3pend"tures# +h",h +asa s!"ht de,rease 'ro200?

;. Sa!es 'or both ,onsuerhea!th produ,ts anded",a! de(",es and

d"anost",s +ere up'ro 200? to 200 by10. per,ent and ;.per,ent# respe,t"(e!y

?. The ,onsuer produ,tsseent/s operat"npro'"t "n,reased 1?.per,ent 'ro 200? toG2#;? "!!"on "n 200

. The Phara,eut",a!seent operat"n pro'"t

"n,reased 1;. per,ent'ro 200?# andoperat"n pro'"t"n,reased to 1.0per,ent to a tota! o'G?#;0 "!!"on "n 200

9. perat"n pro'"t "ned",a! de(",es

"nno(at"(e produ,tun!ess by a,5u"r"nother ,opan"es

. Per 2009 data# the,opany/s 5uarter!y

sa!es dropped by .per,ent 'ro the saeper"od "n pr"or year

;. The se!!"n# enera! andad"n"strat"n e3pensesto sa!es "n,reased by0.0 per,ent 'ro 200?to 200


8/13/2019 David Sm13e Cn 21

12/21

seent "n,reased 9.1per,ent 'ro 200? to atota! o' G?#22 "!!"on "n200

"pportunities

S 2011 Pearson 7du,at"on# n,. pub!"sh"n as Prent",e 4a!!.

8/13/2019 David Sm13e Cn 21

13/21

'ound a ore e''e,t"(eand !ess e3pens"(e +ay"n ad(ert"s"n#edu,at"n# andproot"n the"r produ,ts

(#reats S

8/13/2019 David Sm13e Cn 21

14/21

aount o' oney to et"t tested and re,e"(eDA appro(a!

;. 'ten# drus ,ou!d ha(es"de e''e,ts +h",h

,reate neat"(e pub!","tyand F or 'or,e the,opany to re,a!! thedru or reo(e "t 'rothe she!(es


8/13/2019 David Sm13e Cn 21

15/21

!. SPACE Matrix

$inancial Stabilit2 /$S0 Environmental Stabilit2 /ES0

@eturn on n(estent Inep!oyent -

e(erae Te,hno!o",a! Chanes -

"5u"d"ty Pr",e 7!ast","ty o' Deand -2

8or%"n Cap"ta! Copet"t"(e Pressure -

Cash !o+ Barr"ers to 7ntry -

$inancial Stabilit2 /$S0 Avera&e =.> Environmental Stabilit2 /ES0 Avera&e

8/13/2019 David Sm13e Cn 21

16/21

8/13/2019 David Sm13e Cn 21

17/21

3. (#e 3nternal

8/13/2019 David Sm13e Cn 21

18/21

1e2 $actors %eit

AS (AS AS (AS

"pportunities

1. Sa!!er ,opan"es are ,o"n up +"th ne+and "nno(at"(e drus. Th"s ,reates an

opportun"ty 'or !arer dru ,opan"es toa,5u"re or 'or a 2011 Pearson 7du,at"on# n,. pub!"sh"n as Prent",e 4a!!.

8/13/2019 David Sm13e Cn 21

19/21

anu'a,tur"n the ost e''e,t"(e and h"h-ross"n drus on the ar%et

. ntrodu,"n a ne+ dru "nto the ar%et ,anta%e 10 to 1 years and re5u"re e3tens"(eaount o' oney to et "t tested and

re,e"(e DA appro(a!

0.0 0.20 2 0.1

;. 'ten# drus ,ou!d ha(e s"de e''e,ts +h",h,reate neat"(e pub!","ty and F or 'or,e the,opany to re,a!! the dru or reo(e "t'ro the she!(es

0.0? --- --- --- ---

("(A ).** ).> ).>-

Stren&t#s

1. J&J o''ers a +"de (ar"ety o' produ,ts andser(",es to hosp"ta!s# reta"!ers# and 'a"!"es

0.0 --- --- --- ---

2. The ,opany does bus"ness "n threeseents: phara,eut",a!# ed",a! de(",es

and ,onsuer produ,ts

0.0 0.2 0.2

. n Ju!y 2009# J&J pur,hased an 1.per,ent sta%e "n r"sh b"ote,h ,opany 7!anCorp. "n order to a"n a,,ess to the Gb"!!"on ar%et 'or A!)he"erHs d"seasetreatents. The e''e,t"(eness o' the dru,ou!d he!p the ,opanyHs sa!es by G2b"!!"on

0.0? --- --- --- ---

. n 2009# J&J a,5u"red the sa!! ,an,erdru-de(e!oper Couar B"ote,hno!oy 'orabout G9 "!!"on "n ,ash. Couar has an

e3,e!!ent dru 'or !ate stae prostate,an,er

0.0? --- --- --- ---

. At the end o' 200# J&J reported G?.;b"!!"on "n resear,h and de(e!opentse3pend"tures# +h",h +as a s!"ht de,rease'ro 200?

0.0 --- --- --- ---

;. Sa!es 'or both ,onsuer hea!th produ,tsand ed",a! de(",es and d"anost",s +ereup 'ro 200? to 200 by 10. per,ent and;. per,ent# respe,t"(e!y

0.0; 0.1 0.2

?. The ,onsuer produ,ts seentHs

operat"n pro'"t "n,reased 1?. per,ent'ro 200? to G2#;? "!!"on "n 200

0.0; --- --- --- ---

. The Phara,eut",a! seent operat"npro'"t "n,reased 1;. per,ent 'ro 200?#and operat"n pro'"t "n,reased to 1.0per,ent to a tota! o' G?#;0 "!!"on "n 200

0.0; 0.2 2 0.12

9. perat"n pro'"t "n ed",a! de(",esseent "n,reased 9.1 per,ent 'ro 200?

0.0; --- --- --- ---


8/13/2019 David Sm13e Cn 21

20/21

to a tota! o' G?#22 "!!"on "n 200 --- --- --- ---%ea4nesses

1. Sa!es 'or phara,eut",a! seent +asdo+n 'ro 200? to 200 by 1.2 per,ent

0.0; 0.2 2 0.12

2. Patent on any o' the"r popu!ar and h"h(o!ue drus "s about to e3p"re

0.09 0.; 2 0.1

. n,rease "n tota! !"ab"!"t"es by appro3"ate!yG. b"!!"on 'ro 200? to 200

0.0 --- --- --- ---

. n re,ent years# ha(e not "ntrodu,ed anyne+ "nno(at"(e produ,t un!ess by a,5u"r"nother ,opan"es

0.0? --- --- --- ---

. Per 2009 data# the ,opanyHs 5uarter!ysa!es dropped by . per,ent 'ro thesae per"od "n pr"or year

0.0 --- --- --- ---

;. The se!!"n# enera! and ad"n"strat"n

e3penses to sa!es "n,reased by 0.0per,ent 'ro 200? to 200

0.0? --- --- --- ---

SB("(A ).** ).+= *.

SM ("(A A(('AC(3VE9ESS SC"'E +.*+ -.7-

1. 'ecommendations

A,5u"re ,opan"es that anu'a,ture produ,ts not a(a"!ab!e ,urrent!y throuhJohnson and Johnson produ,t !"ne and ,ou!d 'a!! under one o' the ,opany/spr"ary seent F produ,t !"ne.

. EPS8EB3( Anal2sis

G Aount Needed: G1 b"!!"onSto,% Pr",e: G;.?Ta3 @ate: 2.nterest @ate: .;O Shares utstand"n: 2. b"!!"on

Common Stoc4 $inancin& Debt $inancin&

Recession Normal Boom Recession Normal Boom7BT G2#000#000#000 G0#000#000#000 G#000#000#000 G2#000#000#000 G0#000#000#000 G#000#000

nterest 0 0 0 #;00#000 #;00#000 #;00#00

7BT 2#000#000#000 0#000#000#000 #000#000#000 2?#9#00#000 29#9#00#000 #9#00#

Ta3es ;#0#000#000 ?#00#000#000 10#?#000#000 ;#;?#1;9#000 ?#0?#1;9#000 10#;2#1;9#

7AT 21#20#000#000 22#90#000#000 #2#000#000 21#?#21#000 22#90#21#000 ##21#

O Shares 2#1#;#01 2#1#;#01 2#1#;#01 2#00#000#000 2#00#000#000 2#00#000#0

7PS ;.>) ,.)7 )-.-+ ;.>= ,.), )-.-,


8/13/2019 David Sm13e Cn 21

21/21

;* PercentStoc4 < +*

Percent Debt

;* PercentDebt < +*

Percent Stoc4

Recession Normal Boom Recession Normal Boom

7BT G2#000#000#000 G0#000#000#000 G#000#000#000 G2#000#000#000 G0#000#000#000 G#000#000

nterest #;0#000 #;0#000 #;0#000 10#920#000 10#920#000 10#920#007BT 2?#9;#20#000 29#9;#20#000 #9;#20#000 2?#99#00#000 29#99#00#000 #99#00#

Ta3es ;#;9#?#200 ?#09#?#200 10#;#?#200 ;#??##00 ?#0?##00 10#?2##

7AT 21#;##00 22#91;##00 #91##00 21#11#;;#200 22#91#;;#200 #1;#;;#

O Shares 2#10#12#1 2#10#12#1 2#10#12#1 2#0#;#920 2#0#;#920 2#0#;#9

7PS ;.>) ,.)7 )-.-= ;.>+ ,.), )-.-;

M. Epilo&ue

The ,onress has been d"s,uss"n to pass a nat"ona! hea!th,are prora +h",h

,ou!d "pa,t the dru ,opan"es and ho+ they do bus"ness here "n the In"tedStates. ' the hea!th,are re'or "s passed# ore "nd"("dua!s ,ou!d a''ord to ha(ehea!th "nsuran,e and a,,ord"n!y use produ,ts or ser(",es pres,r"bed by the"rphys","an. n the other hand# there ay be soe re5u"reents "n reards to!o+er"n pr",es on produ,ts or ser(",es by the dru anu'a,turers.

n re,ent onths# Johnson & Johnson has announ,ed se(era! (",tor"es su,h asun(e"!"n Cyto"", Te,hno!oyQ +h",h "s re!ated to ho+ the body/s e!e,tr",a!'"e!d a''e,ts s%"n reress"onR rea,h an areeent bet+een Cord"s Corporat"on*o+ned by Johnson & Johnson +"th Boston S,"ent"'", reso!("n t+o !"t"at"onsRre,e"("n an appro(a! 'ro I.S. ood and Dru Ad"n"strat"on 'or !abe!"n

update 'or Pre)"sta tab!etsR and an "n,rease "n sa!es o' 9.0 per,ent "n 'ourth5uarter o' 2009 ,opared to the sae per"od "n 200.

Documents

David Sm13e Cn 21